---
$id: https://graph.org.ai/products/commodity/51161526
$type: Product
source: UNSPSC
code: "51161526"
title: "Dazoquinast"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dazoquinast

**UNSPSC Code**: 51161526
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anti-asthmatic agent with the molecular formula C11H7N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier A16F9MIN3Z, chemically known as imidazo(1,2-a)quinoxaline-2-carboxylic acid but generally known as dazoquinast, which bears US NIH Compound Identifier 71146. European Medicines Agency schedules Dazoquinast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06924MIG. The term DAZOQUINAST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). DAZOQUINAST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dazoquinast under HS 29339990 and SITC 51577. As of Q4 2014, DAZOQUINAST remains the US FDA Preferred Term for this commodity. Dazoquinast bears US NLM identifiers UMLS ID C2699564 and NCI Concept Code C75138. SMILES: C1=CC=C2C(=C1)N=CC3=NC(=CN23)C(=O)O.

